Status:
RECRUITING
Artificial Intelligence to Measure Adherence to Oral Medication
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
First Episode Psychosis
Eligibility:
All Genders
15-40 years
Phase:
PHASE4
Brief Summary
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Detailed Description
The challenge of oral medication adherence in first-episode psychosis (as in any potentially chronic illness) is enormous, and numerous studies have linked non-adherence to increased rates of relapse/...
Eligibility Criteria
Inclusion
- Enrolled in a CSC program
- Prescribed an oral antipsychotic
Exclusion
- none
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04046497
Start Date
November 20 2020
End Date
December 31 2024
Last Update
September 19 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Citrus Health
Hialeah, Florida, United States, 33012
2
InterAct
Grand Rapids, Michigan, United States, 49503
3
InterAct of Michigan
Kalamazoo, Michigan, United States, 49007
4
Red Rock
Oklahoma City, Oklahoma, United States, 73105